Benjamin R Schrank

17PUBLICATIONS
78CO-AUTHORS
NanomedicineMolecular targetsHaematological tumoursTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 31, 2026
A transferable gut microbiota-bile acid pathway programs nanomedicine pharmacokinetics and therapeutic response.

|Jun 19, 2026
Programming the immunological properties of mRNA vaccines for cancer.

|Mar 10, 2026
Dual phagocytosis-checkpoint blockade revitalizes immune surveillance in mouse models of glioblastoma.

JongHoon Ha, Yifan Wang, Yifan Ma

|Oct 22, 2025
SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade.

Adam J Grippin, Christiano Marconi, Sage Copling

|Jun 12, 2025
Uncovering the hidden landscape of tumour antigens.

Benjamin R Schrank, Betty Y S Kim

|Feb 25, 2025
An antibody-toxin conjugate targeting CD47 linked to the bacterial toxin listeriolysin O for cancer immunotherapy.

Benjamin R Schrank, Yifan Wang, Annette Wu

Pageof 3

Frequent Collaborators

12 joint publications

Wen Jiang

11 joint publications

Wen Jiang

10 joint publications

Yifan Wang

8 joint publications

Shiyan Dong